Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma.

Wu, ZS; Yang, K; Wan, Y; Qian, PX; Perry, Johanna; Chiesa, J; Mertani, HC; Zhu, T; Lobie, Peter

dc.contributor.author	Wu, ZS	en
dc.contributor.author	Yang, K	en
dc.contributor.author	Wan, Y	en
dc.contributor.author	Qian, PX	en
dc.contributor.author	Perry, Johanna	en
dc.contributor.author	Chiesa, J	en
dc.contributor.author	Mertani, HC	en
dc.contributor.author	Zhu, T	en
dc.contributor.author	Lobie, Peter	en
dc.coverage.spatial	United States	en
dc.date.accessioned	2012-03-12T21:27:32Z	en
dc.date.issued	2011	en
dc.identifier.citation	Journal of Clinical Endocrinology and Metabolism 96(10):E1619-E1629 2011	en
dc.identifier.issn	0021-972X	en
dc.identifier.uri	http://hdl.handle.net/2292/14025	en
dc.description.abstract	Evidence suggests that human GH (hGH) and human prolactin (hPRL) possess an autocrine or paracrine oncogenic role in mammary and endometrial carcinoma. However, especially for hGH, the prognostic relevance of tumor expression of these hormones is not well defined.	en
dc.language	eng	en
dc.publisher	The Endocrine Society	en
dc.relation.ispartofseries	Journal of Clinical Endocrinology and Metabolism	en
dc.rights	Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from http://www.sherpa.ac.uk/romeo/issn/0021-972X/	en
dc.rights.uri	https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm	en
dc.subject	Aged	en
dc.subject	Breast Neoplasms	en
dc.subject	Digoxigenin	en
dc.subject	Endometrial Neoplasms	en
dc.subject	Female	en
dc.subject	Human Growth Hormone	en
dc.subject	Humans	en
dc.subject	Immunohistochemistry	en
dc.subject	In Situ Hybridization	en
dc.subject	Kaplan-Meier Estimate	en
dc.subject	Middle Aged	en
dc.subject	Oligonucleotides, Antisense	en
dc.subject	Paraffin Embedding	en
dc.subject	Placental Lactogen	en
dc.subject	Prognosis	en
dc.subject	Prolactin	en
dc.subject	RNA, Messenger	en
dc.subject	Receptor, erbB-2	en
dc.subject	Survival	en
dc.subject	Treatment Outcome	en
dc.subject	Tumor Markers, Biological	en
dc.title	Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma.	en
dc.type	Journal Article	en
dc.identifier.doi	10.1210/jc.2011-1245	en
pubs.issue	10	en
pubs.begin-page	E1619	en
pubs.volume	96	en
dc.rights.holder	Copyright: The Endocrine Society	en
dc.identifier.pmid	21849525	en
pubs.end-page	E1629	en
dc.rights.accessrights	http://purl.org/eprint/accessRights/RestrictedAccess	en
pubs.subtype	Article	en
pubs.elements-id	235138	en
pubs.org-id	Liggins Institute	en
pubs.org-id	Science	en
pubs.org-id	Science Research	en
pubs.org-id	Maurice Wilkins Centre (2010-2014)	en
dc.identifier.eissn	1945-7197	en
dc.identifier.pii	jc.2011-1245	en
pubs.record-created-at-source-date	2012-02-20	en
pubs.dimensions-id	21849525	en